Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effects of omalizumab on T lymphocyte function in inner-city children with asthma.

Literature DB >> 26573086

Effects of omalizumab on T lymphocyte function in inner-city children with asthma.

R S Gruchalla¹, H A Sampson², A H Liu³, W Shreffler⁴, P K Wallace⁵, A Togias⁶, G David⁷, A Calatroni⁷, P LeBeau⁷.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2016 PMID： 26573086 PMCID： PMC4888877 DOI： 10.1111/pai.12508

Source DB: PubMed Journal: Pediatr Allergy Immunol ISSN： 0905-6157 Impact factor: 6.377

× No keyword cloud information.

8 in total

1. Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma.

Authors: Oliver Noga; Gerald Hanf; Ilka Brachmann; Andrea C Klucken; Jörg Kleine-Tebbe; Simone Rosseau; Gert Kunkel; Norbert Suttorp; Joachim Seybold
Journal: J Allergy Clin Immunol Date: 2006-04-27 Impact factor: 10.793

2. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody.

Authors: D W MacGlashan; B S Bochner; D C Adelman; P M Jardieu; A Togias; J McKenzie-White; S A Sterbinsky; R G Hamilton; L M Lichtenstein
Journal: J Immunol Date: 1997-02-01 Impact factor: 5.422

3. Analysis of T cell responses to the major allergens from German cockroach: epitope specificity and relationship to IgE production.

Authors: Carla Oseroff; John Sidney; Victoria Tripple; Howard Grey; Robert Wood; David H Broide; Jason Greenbaum; Ravi Kolla; Bjoern Peters; Anna Pomés; Alessandro Sette
Journal: J Immunol Date: 2012-06-15 Impact factor: 5.422

4. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.

Authors: W Busse; J Corren; B Q Lanier; M McAlary; A Fowler-Taylor; G D Cioppa; A van As; N Gupta
Journal: J Allergy Clin Immunol Date: 2001-08 Impact factor: 10.793

5. Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge.

Authors: John A Eckman; Patricia M Sterba; Denise Kelly; Val Alexander; Mark C Liu; Bruce S Bochner; Donald W Macglashan; Sarbjit S Saini
Journal: J Allergy Clin Immunol Date: 2009-12-04 Impact factor: 10.793

6. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

Authors: James N Francis; Stephen J Till; Stephen R Durham
Journal: J Allergy Clin Immunol Date: 2003-06 Impact factor: 10.793

7. Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa.

Authors: Suzana Radulovic; Mikila R Jacobson; Stephen R Durham; Kayhan T Nouri-Aria
Journal: J Allergy Clin Immunol Date: 2008-04-18 Impact factor: 10.793

8. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.

Authors: Ratko Djukanović; Susan J Wilson; Monica Kraft; Nizar N Jarjour; Mark Steel; K Fan Chung; Weibin Bao; Angel Fowler-Taylor; John Matthews; William W Busse; Stephen T Holgate; John V Fahy
Journal: Am J Respir Crit Care Med Date: 2004-06-01 Impact factor: 21.405

8 in total

5 in total

1. Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy.

Authors: Pamela A Frischmeyer-Guerrerio; Madhan Masilamani; Wenjuan Gu; Erica Brittain; Robert Wood; Jennifer Kim; Kari Nadeau; Kirsi M Jarvinen; Alexander Grishin; Robert Lindblad; Hugh A Sampson
Journal: J Allergy Clin Immunol Date: 2017-04-13 Impact factor: 10.793